Oncology
Oncology is a key segment within the Healthcare sector, comprising 5,981+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Oncology companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
mRNA-based therapeutics for diseases including cancer and infections are developed.
Novel biopharmaceutical medicines are developed for unmet medical needs.
Digital sequencing technology for cancer detection is developed.
Circulating tumor DNA is screened for early cancer detection.
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
Developer of small molecule drugs for the treatment of cancer and inflammatory disease
Small molecule therapeutics are developed for cancer and rare diseases.
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
Developer of drugs based on T-Cell receptor technology for the treatment of cancer
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
Targeted and immune-oncology drugs for cancer treatment are developed.
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
Targeted therapies for cancer treatment are developed.
Non-invasive molecular diagnostic tests for cancer detection are provided.
Small molecule therapeutics for cancer treatment are developed.
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
Biology-guided radiotherapy systems are provided for cancer treatment.
Antibody drugs for cancer treatment are developed.
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Explore Companies in Oncology
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies